Iovance Biotherapeutics
Iovance Biotherapeutics
iovance.com

Locations

San Carlos, CA, USA · North America · New York, NY, USA

industry

Biotechnology · DeepTech · Health

Size

201-1000 employees

Stage

Other

founded in

2007

Iovance Biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL). Under a collaborative research and development agreement with Dr. Steven A. Rosenberg at the National Cancer Institute, we are investigating our our lead product candidate, LN-144, in the treatment of stage 4 metastatic melanoma. In clinical trials, LN-144 has demonstrated curative potential in patients with metastatic melanoma, and it may also be applicable to a wide range of other solid tumors.

Something looks off?
Open jobs at Iovance Biotherapeutics
Powered by Getro